Analytical Characterisation Each batch is analysed using: HPLC for purity assessment Mass spectrometry (MS) for molecular weight confirmation Quality Assurance Batches are produced under controlled laboratory conditions and evaluated against predefined quality criteria to ensure consistency, identity, and purity
When you stop the medication, those mechanisms return to their baseline settings
Reduced appetite, which is a therapeutic effect, not a side effect
Endocrinology 143 (2), 683689
Oral contraceptives semaglutide slows gastric emptying, which may reduce the absorption and effectiveness of oral birth control pills
Abstract Purpose of Review This review explores the rationale and available evidence behind incretin-based therapies for metabolic dysfunction-associated steatotic disease (MASLD) and metabolic-associated steatohepatitis (MASH), focusing on glucagon-like peptide 1 (GLP-1) and glucagon (GCG) receptor dual agonists (GLP-1/GCG RAs)